Docetaxel in combination with rhumab her2 for the treatment...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01) A61K 31/335 (2006.01)

Patent

CA 2368369

The present invention relates to a method of treating cancer, comprising administering a dose of docetaxel and a dose of rhuMAb HER2 to a patient in need thereof, wherein said dosages have a synergistic therapeutic effect when compared to the administration of docetaxel or rhuMAb HER2 alone.

L'invention concerne un procédé de traitement du cancer, consistant à administrer une dose de docétaxel et une dose de rhuMAb HER2 à un patient nécessitant un tel traitement, ces posologies ayant un effet thérapeutique synergique par rapport à l'administration de docétaxel ou de rhuMAb HER2, seul.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Docetaxel in combination with rhumab her2 for the treatment... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Docetaxel in combination with rhumab her2 for the treatment..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Docetaxel in combination with rhumab her2 for the treatment... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1439555

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.